...
首页> 外文期刊>British journal of nursing: BJN >NIVAS 2019: facing the future in vascular access and infusion therapy
【24h】

NIVAS 2019: facing the future in vascular access and infusion therapy

机译:Nivas 2019:面对血管进入和输液治疗的未来

获取原文
获取原文并翻译 | 示例

摘要

In patients with periprosthetic joint infection where surgery is not an option, Dr Ajdukiewicz highlighted the usefulness of continuous antibiotic suppression to manage the infection. Ideally, continuous antibiotic suppression should be associated with high bone penetration, low cumulative toxicity, low risk of drug—drug interactions, long half-life, minimal effect on the gut microbiome and be relatively convenient to take. In the UK, doxycycline, quinolones and cotrimoxazole are commonly used for continuous antibiotic suppression. However, there are limited data available to support the length of time that patients should receive continuous antibiotic suppression; this may contribute to the development of antibiotic resistance. In addition, Dr Ajdukiewicz outlined the role of multi-drug resistant (MDR) plasmids in the development of antibiotic resistance. MDR plasmids are small DNA molecules found in bacterial cells that develop as a result of gene mutations or by acquisition of resistance genes via horizontal gene transfer. Some MDR plasmids also promote biofilm development, thus improving the persistence of MDR plasmids.
机译:在患者患有百血性关节感染的患者中,Ajdukiewicz博士博士突出了持续抗生素抑制来管理感染的有用性。理想情况下,连续的抗生素抑制应与高骨渗透,累积毒性低,药物 - 药物相互作用的低风险,长半衰期,对肠道微生物组的最小影响,采取相对方便。在英国,十二胞环素,喹诺酮和西兰昔唑通常用于连续抗生素抑制。但是,有限的数据可用于支持患者应接受连续抗生素抑制的时间长度;这可能有助于抗生素抗性的发展。此外,AJDukiewicz博士概述了多药物抗性(MDR)质粒在抗生素抗性发展中的作用。 MDR质粒是在细菌细胞中发现的小DNA分子,其由于基因突变或通过水平基因转移而通过耐受抗性基因而产生。一些MDR质粒还促进生物膜发育,从而提高MDR质粒的持续性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号